Physician profile
William K Jeter
NPI 1649290313
$7,431.50
in general payments reported to CMS, 2019-2025
37 companies · $1,043 in 2025
The $1,043 reported for 2025 was more than what 82% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,503 · 2020: $630 · 2021: $894 · 2022: $755 · 2023: $1,384 · 2024: $1,222 · 2025: $1,043.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,622 · Education: $27.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,621.75 |
| Education | $27.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,161.48 | 2021-2025 | |
| Bausch Health US, LLC | $595.61 | 2019-2025 | Wellbutrin, Aplenzin |
| Janssen Pharmaceuticals, INC | $452.73 | 2019-2025 | Spravato, Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $389.83 | 2019-2025 | Rexulti, Abilify Maintena |
| Tris Pharma INC | $380.97 | 2019-2023 | Dyanavel Xr |
| Lundbeck LLC | $367.64 | 2019-2025 | Rexulti |
| Neos Therapeutics, LP | $355.19 | 2019-2024 | Adzenys Xr-Odt |
| Corium, LLC | $302.29 | 2022-2025 | Azstarys |
| Sunovion Pharmaceuticals INC. | $301.95 | 2019-2022 | |
| Ironshore Pharmaceuticals INC. | $275.93 | 2019-2024 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $246.10 | 2019-2025 | Trintellix |
| Validus Pharmaceuticals LLC | $213.57 | 2019-2023 | Equetro |
| Axsome Therapeutics, INC. | $213.56 | 2023-2025 | Auvelity, Sunosi |
| Vanda Pharmaceuticals INC. | $211.51 | 2019-2025 | Fanapt, Hetlioz |
| Neurocrine Biosciences, INC. | $203.68 | 2019-2025 | Ingrezza |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jeter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.